Transient dimerization and interaction with ERGIC-53 occur in the fibroblast growth factor receptor 3 early secretory pathway

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 11, 2008, Pages 2649-2659

  Lievens, Patricia M J ^a,d   De Servi, Barbara ^a   Garofalo, Silvio ^b   Lunstrum, Gregory P ^c   Horton, William A ^c   Liboi, Elio ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

^c SHRINERS HOSPITAL FOR CHILDREN   (United States)

^d ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

ERGIC 53; FGFR3; Quality control; Secretory pathway

Indexed keywords

ENDOPLASMIC RETICULUM GOLGI COMPLEX INTERMEDIATE COMPARTMENT 53 PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 3; MANNOSE; MANNOSE BINDING LECTIN; MONOMER; MUTANT PROTEIN; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; DIMERIZATION; EMBRYO; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLYCOSYLATION; HUMAN; HUMAN CELL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; WILD TYPE;

ANIMALS; BREFELDIN A; CELL LINE; DIMERIZATION; HUMANS; MANNOSE-BINDING LECTINS; MEMBRANE PROTEINS; MICE; MUTATION; PROTEIN SYNTHESIS INHIBITORS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECOMBINANT FUSION PROTEINS; THANATOPHORIC DYSPLASIA;

EID: 48349146353     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.05.017     Document Type: Article

References (32)

1. Appenzeller C., Anderson H., Kappeler F., and Hauri H.P. The lectin ERGIC-53 is a cargo transport receptor for glycoproteins. Nature Cell Biology 1 (1999) 330-334
2. Appenzeller-Herzog C., and Hauri H.P. The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function. Journal of Cell Science 119 (2006) 2173-2183
3. Appenzeller-Herzog C., Nyfeler B., Burkhard P., Santamaria I., Lopez-Otin C., and Hauri H.P. Carbohydrate- and conformation-dependent cargo capture for ER-exit. Molecular Biology of the Cell 16 (2005) 1258-1267
4. Cho J.Y., Guo C., Torello M., Lunstrum G.P., Iwata T., Deng C., et al. Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia. Proceedings of the National Academy of Science USA 101 (2004) 609-614
5. Dailey L., Abrosetti D., Mansukhani A., and Basilico C. Mechanisms underlying differential responses to FGF signaling. Cytokine & Growth Factors Review 16 (2005) 233-247
6. Ellgaard L., Molinari M., and Helenius A. Setting the standards: quality control in the secretory pathway. Science 286 (1999) 1882-1888
7. Gething M.J., and Sambrook J. Protein folding in the cell. Nature 355 (1992) 33-45
8. Gibbs L., and Legai-Mallet L. FGFR3 intracellular mutations induce tyrosine phosphorylation in the Golgi and defective glycosylation. Biochimica et Biophysica Acta 4 (2007) 502-512
9. Glick B.S., and Malhotra V. The curious state of the Golgi apparatus. Cell 95 (1998) 883-889
10. Helenius A., and Aebi M. Roles of N-linked glycans in the endoplasmic reticulum. Annual Review of Biochemistry 73 (2004) 1019-1049
11. Hunter T. Signaling-2000 and beyond. Cell 100 (2000) 113-127
12. Itin C., Roche A.C., Monsigny M., and Hauri H.P. ERGIC53 is a functional mannose selective and calcium-dependent human homologue of leguminous lectins. Molecular Biology of the Cell 7 (1996) 483-493
13. Kan M., Wang F., Xu J., Crabb J.W., Hou J., and McKeehan W.L. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259 (1993) 1918-1921
14. Kaykas A., Yang-Snyder J., Héroux M., Shah K.V., Bouvier M., and Moon R.T. Mutant frizzled 4 associated with vitreoretinophaty traps wild-type Frizzled in the endoplasmic reticulum by oligomerization. Nature Cell Biology 6 (2004) 52-58
15. Keegan K., Meyer S., and Hayman M.J. Structural and biosynthetic characterization of the FGFR3 protein. Oncogene 6 (1991) 2229-2236
16. Klausner R.D., Donaldson J.G., and Lippincott-Schwartz J. Brefeldin A: insight into the control of membrane traffic and organelle structure. Journal of Cell Biology 116 (1992) 1071-1080
17. Lievens P.M.-J., and Liboi E. The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3) which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum. Journal of Biological Chemistry 278 (2003) 17344-17349
18. Lievens P.M.-J., Mutinelli C., Baynes D., and Liboi E. The kinase activity of fibroblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling. Journal of Biological Chemistry 279 (2004) 43254-43260
19. Lievens P.M.-J., Roncador A., and Liboi E. K644E/M FGFR3 mutants activate Erk1/2 from the Endoplasmic Reticulum through FRS2α and PLCγ-independent pathways. Journal of Molecular Biology 357 (2006) 783-792
20. Lippincott-Schwartz J., Donaldson J.G., Schweizer A., Berger E.G., Hauri H.P., Yuan L.P., et al. Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell 60 (1990) 821-836
21. Mitrovic S., Ben-Tekaya H., Koegler E., Gruenberg J., and Hauri H.P. The cargo receptors Surf4, endoplasmic reticulum-golgi intermediate compartment (ERGIC)-53, and p25 are required to maintain the architecture of ERGIC and golgi. Molecular Biology of the Cell 5 (2008) 1976-1990
22. Moussalli M., Pipe S.W., Hauri H.P., Nichols W.C., Ginsburg D., and Kaufman R.J. Mannose-dependent endoplasmic reticulum (ER)-Golgi intermediate compartment-53-mediated ER to Golgi trafficking of coagulation factors V and VIII. Journal of Biological Chemistry 274 (1999) 32539-32542
23. Nichols W.C., Seligsohn U., Zivelin A., Terry V.E., Hertel C.E., Wheatley M.A., et al., Hauri H.P., Kaufman R.J. Mutations in the ER-Golgi intermadiate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 93 (1998) 61-70
24. Nyfeler B., Michnick S.W., and Hauri H.P. Capturing protein interaction in secretory pathway of living cells. Proceedings of the National Academy of Science USA 102 (2005) 6350-6355
25. Pawson T. Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116 (2000) 191-203
26. Plotnikov A.N., Schlessinger J., Hubbard S.R., and Mohammadi M. Structural basis for FGF receptor dimerization and activation. Cell 98 (1999) 641-650
27. Saraste J., and Svensson K. Distribution of the intermediate elements operating in ER to Golgi transport. Journal of Cell Science 100 (1991) 415-430
28. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 103 (2000) 211-225
29. Schmidt-Arras D.E., Bohmer A., Markova B., Choudhary C., Serve H., and Bohmer F.D. Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases. Molecular and Cell Biology 25 (2005) 3690-3703
30. Sitia R., and Braakman I. Quality control in the endoplasmic reticulum protein factory. Nature 426 (2003) 891-894
31. Szebenyi G., and Fallon J.F. Fibroblast growth factors as multifunctional signaling factors. International Review of Cytology 185 (1999) 45-106
32. Zimmerman C.M., and Mathews L.S. Activin receptors: cellular signalling by receptor serine kinases. Biochemical Society Symposia 62 (1996) 25-38